Literature DB >> 27083142

Cholinergic system and cell proliferation.

F J Campoy1, C J Vidal2, E Muñoz-Delgado2, M F Montenegro2, J Cabezas-Herrera3, S Nieto-Cerón3.   

Abstract

The cholinergic system, comprising acetylcholine, the proteins responsible for acetylcholine synthesis and release, acetylcholine receptors and cholinesterases, is expressed by most human cell types. Acetylcholine is a neurotransmitter, but also a local signalling molecule which regulates basic cell functions, and cholinergic responses are involved in cell proliferation and apoptosis. So, activation of nicotinic and muscarinic receptors has a proliferative and anti-apoptotic effect in many cells. The content of choline acetyltransferase, acetylcholine receptors and cholinesterases is altered in many tumours, and cholinesterase content correlates with patient survival in some cancers. During apoptosis, acetylcholinesterase is induced and appears in the nuclei. Acetylcholinesterase participates in the regulation of cell proliferation and apoptosis through hydrolysis of acetylcholine and by other catalytic and non catalytic mechanisms, in a variant-specific manner. This review gathers information on the role of cholinergic system and specially acetylcholinesterase in cell proliferation and apoptosis. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acetylcholine; Acetylcholine receptors; Acetylcholinesterase; Apoptosis; Cancer; Proliferation

Mesh:

Substances:

Year:  2016        PMID: 27083142     DOI: 10.1016/j.cbi.2016.04.014

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  9 in total

Review 1.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

2.  Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia.

Authors:  Oxana Dobrovinskaya; Georgina Valencia-Cruz; Luis Castro-Sánchez; Edgar O Bonales-Alatorre; Liliana Liñan-Rico; Igor Pottosin
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

Review 3.  In Vitro Innervation as an Experimental Model to Study the Expression and Functions of Acetylcholinesterase and Agrin in Human Skeletal Muscle.

Authors:  Katarina Mis; Zoran Grubic; Paola Lorenzon; Marina Sciancalepore; Tomaz Mars; Sergej Pirkmajer
Journal:  Molecules       Date:  2017-08-27       Impact factor: 4.411

Review 4.  The Role of M3 Muscarinic Receptor Ligand-Induced Kinase Signaling in Colon Cancer Progression.

Authors:  Mazen Tolaymat; Shannon M Larabee; Shien Hu; Guofeng Xie; Jean-Pierre Raufman
Journal:  Cancers (Basel)       Date:  2019-03-05       Impact factor: 6.639

5.  Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells.

Authors:  Monika Hudáčová; Slávka Hamuľaková; Eva Konkoľová; Rastislav Jendželovský; Jana Vargová; Juraj Ševc; Peter Fedoročko; Ondrej Soukup; Jana Janočková; Veronika Ihnatova; Tomáš Kučera; Petr Bzonek; Nikola Novakova; Daniel Jun; Lucie Junova; Jan Korábečný; Kamil Kuča; Mária Kožurková
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

6.  Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation.

Authors:  Paulo L Pfitzinger; Laura Fangmann; Kun Wang; Elke Demir; Engin Gürlevik; Bettina Fleischmann-Mundt; Jennifer Brooks; Jan G D'Haese; Steffen Teller; Andreas Hecker; Moritz Jesinghaus; Carsten Jäger; Lei Ren; Rouzanna Istvanffy; Florian Kühnel; Helmut Friess; Güralp Onur Ceyhan; Ihsan Ekin Demir
Journal:  J Exp Clin Cancer Res       Date:  2020-12-24

Review 7.  Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases.

Authors:  Mazen Tolaymat; Margaret H Sundel; Madeline Alizadeh; Guofeng Xie; Jean-Pierre Raufman
Journal:  Front Pharmacol       Date:  2021-11-04       Impact factor: 5.810

Review 8.  Acetylcholine signaling system in progression of lung cancers.

Authors:  Jamie R Friedman; Stephen D Richbart; Justin C Merritt; Kathleen C Brown; Nicholas A Nolan; Austin T Akers; Jamie K Lau; Zachary R Robateau; Sarah L Miles; Piyali Dasgupta
Journal:  Pharmacol Ther       Date:  2018-10-03       Impact factor: 13.400

9.  Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer.

Authors:  Wei Wei; Minggang Wang; Yunglong Li; Qinggui Meng; Yong Tang; Haoyuan Lu; Wenchao Yu; Qiwei Cheng; You Li; Long Xu; Shaojun Jian; Yuexian Wu; Xianlin Yi; Keji Xie
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.